5′-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion
Name
Rajadurai-2016-5'-Inositol phosphat.pdf
Size
3.42 MB
Format
Adobe PDF
Checksum (MD5)
60e3515d312863ff4772e49296995b4b
Author(s) • • • • • • • • •
Rajadurai, Charles V.
Havrylov, Serhiy
Coelho, Paula P.
Ratcliffe, Colin D.H.
Zaoui, Kossay
Huang, Bruce H.
Monast, Anie
Chughtai, Naila
Sangwan, Veena
Siegel, Peter M.
Date Issued
September 2016
Journal
The Journal of Cell Biology
Publisher
Rockefeller University Press
Citation
Rajadurai, Charles V. et al. “5′-Inositol Phosphatase SHIP2 Recruits Mena to Stabilize Invadopodia for Cancer Cell Invasion.” The Journal of Cell Biology 214.6 (2016): 719–734.
Version
Final published version
Abstract
Invadopodia are specialized membrane protrusions that support degradation of extracellular matrix (ECM) by cancer cells, allowing invasion and metastatic spread. Although early stages of invadopodia assembly have been elucidated, little is known about maturation of invadopodia into structures competent for ECM proteolysis. The localized conversion of phosphatidylinositol(3,4,5)-triphosphate and accumulation of phosphatidylinositol(3,4)-bisphosphate at invadopodia is a key determinant for invadopodia maturation. Here we investigate the role of the 5′-inositol phosphatase, SHIP2, and reveal an unexpected scaffold function of SHIP2 as a prerequisite for invadopodia-mediated ECM degradation. Through biochemical and structure-function analyses, we identify specific interactions between SHIP2 and Mena, an Ena/VASP-family actin regulatory protein. We demonstrate that SHIP2 recruits Mena, but not VASP, to invadopodia and that disruption of SHIP2–Mena interaction in cancer cells leads to attenuated capacity for ECM degradation and invasion in vitro, as well as reduced metastasis in vivo. Together, these findings identify SHIP2 as a key modulator of carcinoma invasiveness and a target for metastatic disease.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported license
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1083/jcb.201501003